Juan A. Velasco

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Moritz Schütte, Thomas S. Risch, Nilofar Abdavi-Azar et al. · Nature Communications · 2017 · 349 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468.

Matías A. Ávila, Juan A. Velasco, José Cansado et al. · PubMed · 1994 · 208 citations

Medicine, Oncology, Pharmacology +14

Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures

Karsten Boehnke, Philip W. Iversen, Dirk Schumacher et al. · SLAS DISCOVERY · 2016 · 151 citations · Full text

Medicine, Cell Biology, Oncology +17

Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

Robert M. Campbell, Bryan D. Anderson, Nathan A. Brooks et al. · Molecular Cancer Therapeutics · 2013 · 116 citations

Medicine, Oncology, Pharmacology +13

Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development

Nieves Mijimolle, Juan A. Velasco, Pierre Dubus et al. · Cancer Cell · 2005 · 96 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +14